Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Furman

Showing results (161-170 of 199) with videos related to

Pageof 20
Sort By:
Antiviral Chemistry & Chemotherapy|February 24, 2012
Phosphoramidate prodrugs of (-)-β-D-(2R,4R)-dioxolane-thymine (DOT) as potent anti-HIV agentsPeiyuan Wang, Suguna Rachakonda, Veronique Zennou, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1993
Pharmacokinetics, oral bioavailability, and metabolic disposition in rats of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, a nucleoside analog active against human immunodeficiency virus and hepatitis B virusL W Frick, L St John, L C Taylor, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1992
Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosineR F Schinazi, A McMillan, D Cannon, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2007
The mechanism of action of beta-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine involves a second metabolic pathway leading to beta-D-2'-deoxy-2'-fluoro-2'-C-methyluridine 5'-triphosphate, a potent inhibitor of the hepatitis C virus RNA-dependent RNA polymeraseEisuke Murakami, Congrong Niu, Haiying Bao, et al.
Journal of Virology|April 13, 2012
Structure of hepatitis C virus polymerase in complex with primer-template RNARalph T Mosley, Thomas E Edwards, Eisuke Murakami, et al.
Journal of Virology|December 19, 2000
Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesisY Zhu, T Yamamoto, J Cullen, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1985
3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitroH Mitsuya, K J Weinhold, P A Furman, et al.
Antimicrobial Agents and Chemotherapy|September 4, 2014
Molecular and structural basis for the roles of hepatitis C virus polymerase NS5B amino acids 15, 223, and 321 in viral replication and drug resistanceAngela M Lam, Thomas E Edwards, Ralph T Mosley, et al.
Science (New York, N.Y.)|March 13, 1987
Ribavirin antagonizes the effect of azidothymidine on HIV replicationM W Vogt, K L Hartshorn, P A Furman, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2012
Genotype and subtype profiling of PSI-7977 as a nucleotide inhibitor of hepatitis C virusAngela M Lam, Christine Espiritu, Shalini Bansal, et al.
Pageof 20

Showing results (161-170 of 199) with videos related to

Sort By:
Pageof 20
Antiviral Chemistry & Chemotherapy|February 24, 2012
Phosphoramidate prodrugs of (-)-β-D-(2R,4R)-dioxolane-thymine (DOT) as potent anti-HIV agentsPeiyuan Wang, Suguna Rachakonda, Veronique Zennou, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1993
Pharmacokinetics, oral bioavailability, and metabolic disposition in rats of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, a nucleoside analog active against human immunodeficiency virus and hepatitis B virusL W Frick, L St John, L C Taylor, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1992
Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosineR F Schinazi, A McMillan, D Cannon, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2007
The mechanism of action of beta-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine involves a second metabolic pathway leading to beta-D-2'-deoxy-2'-fluoro-2'-C-methyluridine 5'-triphosphate, a potent inhibitor of the hepatitis C virus RNA-dependent RNA polymeraseEisuke Murakami, Congrong Niu, Haiying Bao, et al.
Journal of Virology|April 13, 2012
Structure of hepatitis C virus polymerase in complex with primer-template RNARalph T Mosley, Thomas E Edwards, Eisuke Murakami, et al.
Journal of Virology|December 19, 2000
Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesisY Zhu, T Yamamoto, J Cullen, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1985
3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitroH Mitsuya, K J Weinhold, P A Furman, et al.
Antimicrobial Agents and Chemotherapy|September 4, 2014
Molecular and structural basis for the roles of hepatitis C virus polymerase NS5B amino acids 15, 223, and 321 in viral replication and drug resistanceAngela M Lam, Thomas E Edwards, Ralph T Mosley, et al.
Science (New York, N.Y.)|March 13, 1987
Ribavirin antagonizes the effect of azidothymidine on HIV replicationM W Vogt, K L Hartshorn, P A Furman, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2012
Genotype and subtype profiling of PSI-7977 as a nucleotide inhibitor of hepatitis C virusAngela M Lam, Christine Espiritu, Shalini Bansal, et al.
Pageof 20